Benjamin Y. Tan

Navitoclax enhances the effectiveness of EGFR-targeted antibody-drug conjugates in PDX models of EGFR-expressing triple-negative breast cancer

A. Letai, R. Bronson, D. Dillon, 2020, Breast cancer research : BCR.

Neutralization of BCL-2/XL Enhances the Cytotoxicity of T-DM1 In Vivo

R. Bronson, D. Dillon, J. Brugge, 2019, Molecular Cancer Therapeutics.

West Nile Virus T-Cell Ligand Sequences Shared with Other Flaviviruses: a Multitude of Variant Sequences as Potential Altered Peptide Ligands

T. Tan, V. Brusic, F. Lemonnier, 2012, Journal of Virology.

The tale of TILs in breast cancer: A report from The International Immuno-Oncology Biomarker Working Group

Andrew H. Beck, Clare C. Yu, M. N. Vidya, 2021, npj Breast Cancer.